We encountered a patient with advanced ICC with a BRCA2 mutation, which was successfully treated with preoperative GCS therapy followed by surgical resection, and a pathologic complete response was achieved. The gene discussed is BRCA2; the disease is intrahepatic cholangiocarcinoma.